THR Hospitals Offer Drug-Coated Stents|
ARLINGTON, Texas — Cardiologists at Presbyterian Hospital of Dallas, Harris Methodist Fort Worth Hospital and Harris Methodist H•E•B Hospital performed procedures Friday, April 25, 2003, using a new drug-coated stent designed to keep arteries from reclogging after angioplasty.
Presbyterian Hospital of Plano and Arlington Memorial Hospital are expected to receive the new stents in upcoming weeks.
The Food and Drug Administration approved the stent Thursday, April 24, 2003, after studies suggested a potential 60 percent reduction in the chance of a heart attack or need for additional treatment compared to uncoated stents. "This is a significant breakthrough," said FDA Commissioner Mark McClellan.